HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eva Lengfelder Selected Research

Eva Lengfelder Research Topics

Disease

13Acute Promyelocytic Leukemia
12/2021 - 01/2002
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2018 - 01/2003
5Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2021 - 12/2005
4B-Cell Lymphoma (Lymphoma, B Cell)
07/2023 - 02/2008
4Hemorrhage
12/2020 - 02/2009
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
07/2021 - 12/2005
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2015 - 02/2008
3Polycythemia Vera
07/2013 - 04/2006
3Myeloproliferative Disorders (Myeloproliferative Disorder)
10/2006 - 09/2005
1Lymphoma (Lymphomas)
12/2019
1Hematologic Neoplasms (Hematological Malignancy)
04/2013
1Leukemia
01/2013
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2009
1Hyperplasia
05/2009
1Fibrosis (Cirrhosis)
05/2009
1Pdgfra-Associated Chronic Eosinophilic Leukemia
10/2006
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2006
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2006
1Essential Thrombocythemia
10/2005
1Stroke (Strokes)
10/2005
1Genetic Translocation (Chromosomal Translocation)
09/2005

Drug/Important Bio-Agent (IBA)

7Rituximab (Mabthera)FDA Link
07/2023 - 12/2005
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2023 - 12/2005
6Vincristine (Oncovin)FDA LinkGeneric
07/2023 - 12/2005
6Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2021 - 02/2009
5Doxorubicin (Adriamycin)FDA LinkGeneric
07/2023 - 12/2005
5Arsenic Trioxide (Trisenox)FDA Link
12/2021 - 02/2009
4Prednisone (Sone)FDA LinkGeneric
12/2019 - 12/2005
4Cytarabine (Cytosar-U)FDA LinkGeneric
12/2018 - 12/2003
4Mitoxantrone (Novantrone)FDA LinkGeneric
12/2018 - 12/2003
3Imatinib Mesylate (Gleevec)FDA Link
07/2013 - 04/2006
2Prednisolone (Predate)FDA LinkGeneric
04/2012 - 02/2008
2Messenger RNA (mRNA)IBA
05/2010 - 10/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2006 - 09/2005
1RNA (Ribonucleic Acid)IBA
12/2020
1MetallothioneinIBA
12/2020
1Biomarkers (Surrogate Marker)IBA
12/2020
1AnthracyclinesIBA
02/2018
1Tyrosine Kinase InhibitorsIBA
07/2013
1Proto-Oncogene Proteins c-etsIBA
04/2013
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2013
1Transcription Factors (Transcription Factor)IBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
08/2012
1Alemtuzumab (Campath)FDA Link
08/2009
1fludarabineIBA
08/2009
1Reticulin (Reticular Fiber)IBA
05/2009
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
10/2006
1Chlorambucil (Leukeran)FDA Link
09/2006
1Busulfan (Busulfex)FDA Link
06/2006
1Interferon-alpha (Interferon Alfa)IBA
04/2006
1Monoclonal AntibodiesIBA
12/2005
1AcidsIBA
11/2005
1InterferonsIBA
10/2005
1Daunorubicin (Cerubidine)FDA LinkGeneric
12/2003
1Thioguanine (Tioguanine)FDA Link
12/2003
1promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA
01/2002

Therapy/Procedure

16Therapeutics
12/2021 - 01/2003
8Drug Therapy (Chemotherapy)
01/2020 - 12/2005
2Radiotherapy
07/2023 - 12/2019
2Salvage Therapy
11/2019 - 02/2009
1Aftercare (After-Treatment)
01/2020
1Induction Chemotherapy
01/2009
1Stem Cell Transplantation
06/2006
1Maintenance Chemotherapy
12/2003